- Home
- Generic and Biogeneric Drugs for 15 Major Therapeutic Categories%20
Generic and Biogeneric Drugs for 15 Major Therapeutic Categories%20
This market research, not available anymore on the publisher's website, was withdrawn from our database.
To get an alternative report, you can either :
- Have a look at the list of documents hereafter
- Launch a new search below
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
DOWNLOAD THESE REPORTS NOW!
Biopharmaceutical in Japan: Keryx Biopharmaceuticals, Inc. ? Product Pipeline Review - H2 2011
- $ 500
- Company report
- by Global Markets Direct
- May 2012
- 85 pages
- Product Pipeline Review - H2 2011? provides a detailed overview on the Keryx Biopharmaceuticals, Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using ...
Industries: Biopharmaceutical | Countries: Japan, World
Global Medical Biosensors Market 2011-2015
- $ 1 500
- Industry report
- by Infiniti Research Limited
- May 2012
- 36 pages
TechNavio's analysts forecast the Global Medical Biosensors market to grow at a CAGR of 9.4 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increased sales of glucose monitoring devices. The Global Medical Biosensors market has also been witnessing ...
Industries: Biotechnology | Countries: World
Global Industrial Enzymes Market Report: 2012 Edition
- $ 800
- Industry report
- by Koncept Analytics
- May 2012
- 37 pages
Enzymes are known to play a crucial role as a metabolic catalyst in the development of life, since the advent of civilization. However, scientific research over a long period has discovered the actual functioning of enzymes, leading to their increased usage in various industries and applications. The ...
Industries: Biopharmaceutical | Countries: World
Cryo-Save Group N.V. (Symbol:CRYO) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- by Global Data
- May 2012
- 31 pages
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Cryo-Save Group N.V. SWOT Analysis report provides you a strategic ...
Industries: Biological Therapy | Countries: Europe, South Africa, World, Africa, Netherlands
Illumina, Inc. (Symbol:ILMN) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- by Global Data
- May 2012
- 46 pages
Illumina, Inc. (Illumina) is a molecular diagnostics company that principally focuses on the research and development of DNA and RNA Assays. It is involved in the development, manufacture and marketing of integrated systems for the analysis of genetic variation and biological function through its technologies. ...
Industries: Genomics | Countries: United States, World, Saudi Arabia
CSL Limited (Symbol:CSL) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- by Global Data
- May 2012
- 44 pages
CSL Limited (CSL) is a global biopharmaceutical company, engaged in the research, development, manufacture, marketing and distribution of pharmaceutical products. The company is principally focused on the development and manufacture of vaccines and plasma protein biotherapies for the treatment and prevention ...
Industries: Biopharmaceutical | Countries: Australia, United States, World
8th Annual Report and Survey of Biopharmaceutical Manufacturing
- $ 845
- Industry report
- by BioPlan Associates, Inc.
- May 2012
- 492 pages
Coverage This report's 492 pages of data-rich analysis will help improve your decision-making in biomanufacturing operations, with in-depth analysis of capacity, production trends, benchmarks, and much more: ? Budget impact of current economic environment ? Downstream purification problems and issues ...
Industries: Biopharmaceutical | Countries: United States, World, Europe
Cetuximab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
- $ 1 363
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Biological Therapy | Countries: Europe, World
Darbepoetin alfa - Key patent, SPC, and data exclusivity expiry (44 country coverage)
- $ 1 363
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Biopharmaceutical | Countries: Europe, World
Imiquimod - Key patent, SPC, and data exclusivity expiry (44 country coverage)
- $ 1 363
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Biological Therapy | Countries: Europe, World
24/7 Customer Service
You can call our customer service 24 hours a day / 7 days a week
- (866) 682 9815
Reportlinker.com © Copyright 2012. All rights reserved
